Home / Therapies / Insulin Therapy Center (page 2)

Insulin Therapy Center

Insulin Therapy for Diabetes: Diabetes in Control answers key questions about the uses and challenges of insulin in diabetes management, including:
– How insulin is used to treat diabetes
– How/when a healthcare professional should consider insulin therapy for diabetes patients
– What a healthcare professional needs to know about making insulin therapy safe and effective

The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care

Insulin pens beside an FDA symbol and prescription form representing interchangeable insulin biosimilars and pharmacy-level insulin switching in diabetes care.

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Read More »

Once-Weekly Basal Insulin: Does Simplicity Improve Adherence?

Close-up of a once-weekly basal insulin pen held by a patient with glucose meter and weekly pill organizer in the background

The arrival of a once-weekly basal insulin option marks one of the most meaningful advances in insulin therapy in decades. For years, daily basal injections have been the standard of care for people with type 1 and type 2 diabetes. However, many patients struggle with adherence, missed doses, and therapeutic …

Read More »

Reimagining Remission: Can Short‑Term Intensive Therapy Reset Type 2 Diabetes?

A diabetes management setup featuring a glucose meter, vegetables, apple, insulin pen, and a notepad labeled "Intensive Therapy"

Could the conventional “lifelong treatment” model for type 2 diabetes be rethought? Recent trials suggest that short‑term intensive therapy may offer more than transient glycemic control—it might trigger lasting remission in newly diagnosed patients. Such interventions, combining aggressive pharmacologic therapy or insulin with lifestyle change, show potential to preserve β‑cell …

Read More »

The Case for Early Insulin: Rethinking Delayed Initiation in Type 2 Diabetes

A female doctor explains insulin injection using a pen device to a middle-aged male patient, with a glucose monitor and tablet displaying a blood sugar graph on the table.

Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …

Read More »